Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With Ions
This study is looking at a new, faster way to give radiation therapy for soft tissue sarcoma, a type of cancer that can affect the arms or legs. Instead of the usual five weeks, this treatment lasts only two to three weeks. It uses advanced types of radiation, called protons or carbon ions, which are designed to target the cancer more precisely. The main goals are to see if this new treatment is safe, if it helps with wound healing after surgery, and if it could lead to fewer long-term side effects than standard radiation. By making the treatment shorter and potentially safer, researchers hope to improve the quality of life for patients and the overall effectiveness of care.
At a glance
What is this study about?
This research study is looking at new ways to treat a type of cancer called soft tissue sarcoma, which can grow in the arms or legs. Usually, doctors treat this cancer with surgery to remove it, combined with radiation therapy. Radiation helps kill any cancer cells that might be left behind and reduces the chance of the cancer coming back.
Traditionally, radiation therapy can be given after surgery. However, giving radiation *before* surgery (called neoadjuvant radiation) can sometimes be better because it targets a smaller area and uses a slightly lower dose of radiation. The challenge with radiation before surgery has been that it can sometimes make wound healing after the operation more difficult. This study hopes to solve that problem.
Researchers are using special types of radiation called proton therapy and carbon ion therapy. These advanced radiation treatments are designed to deliver radiation more precisely to the cancer, sparing healthy tissues nearby. This precision could mean fewer side effects and better wound healing. Also, the new treatment schedule is much shorter – just two to three weeks compared to the usual five weeks – which could be a big help for patients. The aim is to see if this shorter, more precise treatment is safe and effective, and whether it leads to better outcomes with fewer issues during recovery.
Key takeaways
- Tests a new, shorter radiation for arm/leg soft tissue sarcoma.
- Uses advanced 'proton' or 'carbon ion' radiation for precision targeting.
- Aims to reduce radiation duration (2-3 weeks vs. 5 weeks).
- Hopes to improve wound healing after surgery and reduce long-term side effects.
- This is a Phase 2 study, meaning it's still in early stages of testing safety and effectiveness.
Who may be eligible?
To be considered for this study, you would need to have soft tissue sarcoma in your arms or legs that doctors plan to treat with both surgery and radiation. The cancer must be able to be removed by surgery, and you should generally be in good health. You must be at least 18 years old and capable of understanding the study and agreeing to take part.
You would not be able to join if your cancer has spread to other parts of your body or to your lymph nodes. If you have metal implants that would interfere with the special radiation treatment, or if you've already had radiation in the area being treated, you would also not be able to participate. Certain other conditions, like having a specific type of tumor called a desmoid tumor or certain medical devices, might also prevent you from joining.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Do I have soft tissue sarcoma in my arm or leg?
- Do doctors say my cancer can be removed by surgery?
- Am I at least 18 years old?
- Is my general health good enough for a clinical trial?
- Has my cancer not spread to other parts of my body or lymph nodes?
- Do I need perioperative radiation treatment (radiation given around the time of surgery)?
What does participation involve?
If you decide to take part, you would receive the new radiation treatment using either protons or carbon ions before your surgery. This treatment would last for about two to three weeks. Doctors would carefully monitor your recovery, especially how your wounds heal after surgery, for up to four months. You would have regular appointments to check on your health and side effects. The exact number of visits and follow-up activities would be explained in detail by the study team.
Potential risks and benefits
Locations (1)
- University Hospital Heidelberg, Department of RadioOncologyVerified postcodeHeidelberg, Germany· Recruiting
Common questions
What is soft tissue sarcoma?
It's a rare type of cancer that can form in soft tissues of the body, like muscle, fat, blood vessels, or nerves. This study focuses on sarcomas in the arms or legs.
What are protons and carbon ions?
These are advanced forms of radiation that can target cancer more precisely than traditional radiation, potentially causing less damage to healthy tissues nearby.
Why is this treatment shorter?
The new treatment schedule uses fewer, but slightly stronger, doses of radiation over two to three weeks, compared to the usual five weeks, which could make it more convenient for patients.
Will this improve my wound healing?
That's one of the main questions this study aims to answer. Researchers hope this new approach will lead to fewer wound healing problems after surgery.
recruiter: Will this treatment replace my current care?
This is a research study exploring a new treatment option. If you qualify and choose to participate, this treatment would be part of your overall care plan, but it's not yet a standard treatment.
How to find out more
Klaus Herfarth, Prof. Dr.
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.